Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion

Increasing evidence suggests that liquid biopsy might play a relevant role in the management of metastatic non-small cell lung cancer (NSCLC) patients. Here, we show how the Molecular Tumor Board (MTB) in our cancer center employed liquid biopsy to support therapeutic decisions in a patient with NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Morabito, Alessandro, Manzo, Anna, Montanino, Agnese, Rachiglio, Anna Maria, Sforza, Vincenzo, Pasquale, Raffaella, Costanzo, Raffaele, Maiello, Monica R, Sandomenico, Claudia, Gallo, Marianna, Palumbo, Giuliano, De Luca, Antonella, La Rocca, Antonello, Martucci, Nicola, De Cecio, Rossella, Picone, Carmine, Lastoria, Secondo, Normanno, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Precision Medicine Clinic: Molecular Tumor Board
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842466/
https://www.ncbi.nlm.nih.gov/pubmed/35305107
http://dx.doi.org/10.1093/oncolo/oyab002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842466/
https://www.ncbi.nlm.nih.gov/pubmed/35305107
http://dx.doi.org/10.1093/oncolo/oyab002

Ejemplares similares